J&J Medical Device Chief Steps Down After Improper Payments Are Disclosed
This article was originally published in The Gray Sheet
Executive Summary
Worldwide chairman of Johnson & Johnson's medical devices and diagnostics business Michael Dormer abruptly retired Feb. 12 following J&J's disclosure that foreign subsidiaries may have made improper payments in the course of marketing activities
You may also be interested in...
News In Brief
FDA Office of Device Evaluation director
News In Brief
FDA Office of Device Evaluation director
Former J&J exec charged with bribery
Robert John Dougall, former VP of market development at J&J's DePuy International branch in Leeds, was charged with conspiracy to corrupt in a U.K. court Dec. 1. The former device exec is accused of "making corrupt payments and/or giving other inducements to medical professionals" in Greece between February 2002 and December 2005 to encourage them to purchase orthopedic products from J&J/DePuy, according to the U.K.'s Serious Fraud Office. The case was referred to the office by the U.S. Department of Justice in March 2008. Chief Magistrate District Judge Timothy Workman sent the case to England's Crown Court at Southwark, where Dougall is set to appear Feb. 3. Former worldwide chairman of J&J's medical device and diagnostics business Michael Dormer had stepped down in February 2007 after the company disclosed that foreign subsidiaries may have made improper payments in "two small-market countries" (1"The Gray Sheet" Feb. 19, 2007)